Acter (5536) Q3 2025 earnings summary

Executive summary

• Consolidated revenue for the first three quarters of 2025 reached NT$30.51 billion, a historical high, with EPS also at a record NT$20.35 (par value NT$5).

• Net income attributable to owners for the nine months was NT$2,525,096 thousand, compared to NT$1,872,664 thousand in the prior year period.

• The company operates in 10 countries with 28 companies, serving diverse industries including semiconductors, electronics, and healthcare.

• Backlog remains robust at over NT$46 billion, supporting future operations.

• The group maintained a robust cash position with NT$9,434,800 thousand in cash and equivalents as of September 30, 2025.

Financial highlights

• Operating revenue for 2025 Q1–Q3 increased to NT$30.51 billion from NT$20.76 billion year-over-year.

• Gross profit rose to NT$5.61 billion, and operating income to NT$4.17 billion for 2025 Q1–Q3.

• Basic EPS for the nine months was NT$20.35, compared to NT$15.09 in the prior year period.

• Net profit after tax attributable to the parent was NT$2.53 billion for 2025 Q3.

• Net cash provided by operating activities was NT$2,853,355 thousand for the nine months, up from NT$1,904,609 thousand year-over-year.

Outlook and guidance

• High backlog of NT$46 billion ensures strong revenue visibility into 2026.

• Cleanroom and semiconductor markets expected to grow, with global cleanroom market projected to reach USD 14.16 billion by 2030 at a 7.11% CAGR.

• Focus on net zero carbon opportunities and green engineering to capture future demand.

• The group expects no significant impact from new IFRS standards effective in 2026 and is evaluating the impact of IFRS 18, which will be adopted in Taiwan in 2028.

• Management continues to monitor market and regulatory developments for potential impacts on financial reporting.